⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Acumetis and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Acumetis
↗Yardley, USA
Acumetis is a global life sciences commercialization consultancy formed in April 2026 through the merger of five specialist firms: Herspiegel, Adivo Associates, Decisive Consulting, FIECON, and Sixsense Strategy Group. The company provides an integrated service model spanning the entire asset lifecycle, including commercial strategy, launch excellence, patient access, health economics and outcomes research (HEOR), and medical affairs.
Headquartered in Yardley, Pennsylvania, with a global footprint across the US, Canada, South America, Europe, and India, Acumetis employs over 350 specialists. The firm is backed by private equity firm DFW Capital Partners and serves more than 150 life sciences organizations, including many of the world's top global pharmaceutical companies.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Life Sciences Commercialization Consulting
SIZE & FINANCIALS
Employees:201-500
Founded:2026
Ownership:private
Status:operating
FUNDING
Stage:Private Equity Backed
Investors:DFW Capital Partners
0
CORPORATE STRUCTURE
Key Partnerships:BrandingBusiness (Branding/Marketing partner)
COMPETITION
Position:Emerging
Competitors:IQVIA, Syneos Health, ZS Associates, ClearView Healthcare Partners
LEADERSHIP
Key Executives:
Brent Herspiegel - CEO
LINKS
Website:acumetisglobal.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Acumetis. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.